Morgan Stanley’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $725M | Buy |
|
|||||
|
2023
Q3 | $107M | Sell |
|
|||||
|
2023
Q2 | $103M | Buy |
|
|||||
|
2023
Q1 | $76.3M | Buy |
|
|||||
|
2022
Q4 | $76.6M | Buy |
|
|||||
|
2022
Q3 | $68.9M | Buy |
|
|||||
|
2022
Q2 | $60.8M | Buy |
|
|||||
|
2022
Q1 | $10.3M | Buy |
|
|||||
|
2021
Q4 | $3.92M | Sell |
|
|||||
|
2021
Q3 | $5.87M | Sell |
|
|||||
|
2021
Q2 | $12.4M | Buy |
|
|||||
|
2021
Q1 | $9.19M | Sell |
|
|||||
|
2020
Q4 | $48.3M | Buy |
|
|||||
|
2020
Q3 | $5.06M | Buy |
|
|||||
|
2020
Q2 | $3.06M | Sell |
|
|||||
|
2020
Q1 | $2.22M | Sell |
|
|||||
|
2019
Q4 | $18.5M | Buy |
|
|||||
|
2019
Q3 | $3.16M | Buy |
|
|||||
|
2019
Q2 | $1.78M | Buy |
|
|||||
|
2019
Q1 | $956K | Sell |
|
|||||
|
2018
Q4 | $2.1M | Sell |
|
|||||
|
2018
Q3 | $2.51M | Buy |
|
|||||
|
2018
Q2 | $2.19M | Buy |
|
|||||
|
2018
Q1 | $454K | Sell |
|
|||||
|
2017
Q4 | $290K | Sell |
|
|||||
|
2017
Q3 | $1.94M | Buy |
|
|||||
|
2017
Q2 | $116K | Sell |
|
|||||
|
2017
Q1 | $276K | Sell |
|
|||||
|
2016
Q4 | $329K | Buy |
|
|||||
|
2016
Q3 | $247K | Sell |
|
|||||
|
2016
Q2 | $419K | Buy |
|
|||||
|
2016
Q1 | $1.03M | Sell |
|
|||||
|
2015
Q4 | $4.47M | Buy |
|
|||||
|
2015
Q3 | $4.5M | Buy |
|
|||||
|
2015
Q2 | $1.67M | Buy |
|
|||||
|
2015
Q1 | $493K | Sell |
|
|||||
|
2014
Q4 | $643K | Buy |
|
|||||
|
2014
Q3 | $474K | Buy |
|
|||||
|
2014
Q2 | $419K | Sell |
|
|||||
|
2014
Q1 | $1.05M | Buy |
|
|||||
|
2013
Q4 | $158K | Buy |
|